Xiaohui Yang

Title: Innovations of Xiaohui Yang in Asymmetric Catalytic Hydrogenation

Introduction

Xiaohui Yang is a notable inventor based in Tianjin, China. He has made significant contributions to the field of asymmetric catalytic hydrogenation, particularly in the kinetic resolution of racemic hydroxy esters. His work has implications for the synthesis of chiral drugs, showcasing the importance of innovation in pharmaceutical chemistry.

Latest Patents

Xiaohui Yang holds a patent titled "Kinetic resolution of racemic hydroxy ester via asymmetric catalytic hydrogenation and application thereof." This invention focuses on the kinetic resolution of racemic δ-hydroxyl esters using a chiral spiro pyridyl phosphine ligand iridium catalyst and a base. The process allows for the production of optically pure chiral δ-hydroxyl esters and corresponding 1,5-diols with high enantioselectivity and yield, utilizing relatively low amounts of catalyst. The resulting chiral compounds are critical raw materials for the asymmetric synthesis of various chiral drugs, including (R)-lisofylline and natural drugs such as (+)-civet and (−)-indolizidine 167B.

Career Highlights

Xiaohui Yang is associated with Zhejiang Jiuzhou Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His innovative approaches in asymmetric synthesis have positioned him as a key figure in the pharmaceutical industry.

Collaborations

Xiaohui has collaborated with notable colleagues, including Qilin Zhou and Jianhua Xie, to further enhance the impact of his research. These collaborations have fostered a productive environment for innovation and development in their field.

Conclusion

Xiaohui Yang's contributions to asymmetric catalytic hydrogenation exemplify the vital role of inventors in advancing pharmaceutical sciences. His innovative patent work not only enhances the efficiency of drug synthesis but also underscores the importance of collaboration in achieving significant breakthroughs.